NN7088-3860 – Efficacy and Safety of NNC 0129-0000-1003 During Surgical Procedures in Patients with Haemophilia A

Service: Trial Number:
Principal Investigator: Conducted at:
Miller Children's & Women's Hospital Long Beach
Currently enrolling additional patients:
Age Range:
7-17 years; 18 years & up
Male & Female

This clinical trial conducted by conducted by Paula Groncy, MD and her team at the MemorialCare Health System is called Pathfinder3. Participation on this study is for patients have hemophilia A and are scheduled to undergo a surgery, which will require several days of treatment with N8-GP. These patients are also already receiving the trial drug N8-GP from the Pathfinder2 trial. The purpose of this research trial is to evaluate the effectiveness of N8-GP in preventing bleeding during surgery and in stopping bleeding during and after surgery and also to allow you to continue treatment with N8-GP during your surgery procedure.